Cargando…
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
BACKGROUND: Current influenza vaccines deliver satisfactory results in young people but are less effective in the elderly. Development of vaccines for an ever-increasing aging population has been an arduous challenge due to immunosenescence that impairs the immune response in the aged, both quantita...
Autores principales: | Park, Bo Ryoung, Bommireddy, Ramireddy, Chung, David Hyunjung, Kim, Ki-Hye, Subbiah, Jeeva, Jung, Yu-Jin, Bhatnagar, Noopur, Pack, Christopher D., Ramachandiran, Sampath, Reddy, Shaker J.C., Selvaraj, Periasamy, Kang, Sang-Moo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173218/ https://www.ncbi.nlm.nih.gov/pubmed/37170231 http://dx.doi.org/10.1186/s12979-023-00344-w |
Ejemplares similares
-
Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer Models
por: Munoz, Luis E., et al.
Publicado: (2021) -
Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
por: Bhatnagar, Noopur, et al.
Publicado: (2023) -
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
por: Munoz, Luis Enrique, et al.
Publicado: (2021) -
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses
por: Bommireddy, Ramireddy, et al.
Publicado: (2022) -
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer
por: Bommireddy, Ramireddy, et al.
Publicado: (2020)